More than 43,000 people in the United States developed HPV-associated cancers in 2015, compared with about 30,000 in 1999. At the same time, the HPV vaccination rates – a trend that could eventually curb the increase in cancer cases – are rising do not get up fast enough.
Human papillomavirus cancers have increased significantly in the United States in the past 15 years, with throat cancer being the most common HPV-associated malignancy, the Centers for Disease Control and Prevention reported.
More than 43,000 people fell ill with HPV-associated cancers in 201
At the same time, the CDC said the HPV vaccination rates are rising – a trend that could eventually curb the increase of cancer cases. But the vaccination rate is not rising fast enough, experts say. Almost half of adolescents aged 13 to 17 in 2017 received all recommended doses for HPV vaccination, while two-thirds received the first dose. This was an increase of five percentage points over the previous year for both groups.
"We are moving in the right direction, but given the fact that we have a safe and effective vaccine, there are few reasons for parents and providers" We do not vaccinate every single child, "said Ronald DePinho, a former president MD Anderson Cancer Center.
"Using a vaccine that can prevent cancer is a missed opportunity and a tragic one," he added.
HPV is the most common sexually transmitted infection among nearly 80 million Americans In most cases, the body's immune system eliminates the infection, but in some cases certain strains of HPV persist and can cause cervical cancer as well as some types of cervical, vaginal, penile and anal cancers.
The Agency The vaccines could prevent 90 percent of HPV-related cancer cases – those that can be directly attributed to HPV – every year With the introduction of the vaccine a decade ago, HPV infections and cervical precancerous disease have declined significantly. However, it may take a long time for the benefits of the vaccine to become apparent, as many cancers can not develop after several years after HPV infection.
The Agency recommends two doses of the HPV vaccine to children aged 11 to 12 for six to twelve months. Those who receive the first dose after their 15th birthday should receive three shots.
External experts welcomed the increased HPV vaccination rates, but said that much more improvement is needed.
Larry Copeland, a gynecological oncologist at The James, Ohio State The University Comprehensive Cancer Center agreed, saying it was "not at all satisfying" that more than 50 percent of adolescents did not complete the HPV vaccine series.
"The medical community must be blamed for this," Copeland said that some patients with HPV-related cervix cancer tell him that the vaccine was not recommended by their doctors. "We have to look in the mirror, paediatricians, family doctors, come on, let's start the program."
The report showed that fewer youth in rural areas than in urban areas receive HPV vaccine as well as a recommended meningitis vaccine. And boys still stay girls while receiving the HPV vaccine; About 53 percent of the girls received all recommended doses, while 44 percent of the boys received them.
Between 1999 and 2015, rates of throat cancer increased in men and women, but more in men, the CDC Washington Post said